Mijal Munster

1.2k total citations
51 papers, 878 citations indexed

About

Mijal Munster is a scholar working on Biomedical Engineering, Molecular Biology and Biotechnology. According to data from OpenAlex, Mijal Munster has authored 51 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Biomedical Engineering, 22 papers in Molecular Biology and 13 papers in Biotechnology. Recurrent topics in Mijal Munster's work include 3D Printing in Biomedical Research (13 papers), Cancer Research and Treatments (10 papers) and Nanoplatforms for cancer theranostics (9 papers). Mijal Munster is often cited by papers focused on 3D Printing in Biomedical Research (13 papers), Cancer Research and Treatments (10 papers) and Nanoplatforms for cancer theranostics (9 papers). Mijal Munster collaborates with scholars based in United States, Switzerland and Portugal. Mijal Munster's co-authors include Moshe Giladi, Yoram Palti, Rosa S. Schneiderman, Eilon D. Kirson, Yaara Porat, Uri Weinberg, Tali Voloshin, Anna Shteingauz, Roni Blat and Shay Cahal and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Mijal Munster

49 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mijal Munster United States 12 414 338 238 190 158 51 878
Shay Cahal United States 7 266 0.6× 276 0.8× 166 0.7× 119 0.6× 116 0.7× 22 640
Roni Blat Switzerland 7 295 0.7× 217 0.6× 155 0.7× 130 0.7× 110 0.7× 21 580
Anna Shteingauz Israel 13 288 0.7× 261 0.8× 415 1.7× 139 0.7× 147 0.9× 40 969
Tali Voloshin Israel 19 495 1.2× 441 1.3× 490 2.1× 232 1.2× 404 2.6× 79 1.4k
Einav Zeevi United States 8 193 0.5× 178 0.5× 142 0.6× 92 0.5× 91 0.6× 33 465
Noa Kaynan Israel 9 162 0.4× 143 0.4× 121 0.5× 80 0.4× 122 0.8× 26 471
Manuela Silginer Switzerland 16 361 0.9× 155 0.5× 415 1.7× 101 0.5× 344 2.2× 31 1.0k
Almuth F. Keßler Germany 16 275 0.7× 88 0.3× 203 0.9× 101 0.5× 209 1.3× 57 704
Sonia Tejada Spain 15 822 2.0× 217 0.6× 185 0.8× 228 1.2× 442 2.8× 34 1.2k
Eduard B. Dinca United Kingdom 11 284 0.7× 109 0.3× 251 1.1× 97 0.5× 111 0.7× 17 658

Countries citing papers authored by Mijal Munster

Since Specialization
Citations

This map shows the geographic impact of Mijal Munster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mijal Munster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mijal Munster more than expected).

Fields of papers citing papers by Mijal Munster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mijal Munster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mijal Munster. The network helps show where Mijal Munster may publish in the future.

Co-authorship network of co-authors of Mijal Munster

This figure shows the co-authorship network connecting the top 25 collaborators of Mijal Munster. A scholar is included among the top collaborators of Mijal Munster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mijal Munster. Mijal Munster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blatt, Roni, Mijal Munster, Anna Shteingauz, et al.. (2021). In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso. Frontiers in Oncology. 11. 670809–670809. 20 indexed citations
2.
Voloshin, Tali, Noa Kaynan, Yaara Porat, et al.. (2020). Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. Cancer Immunology Immunotherapy. 69(7). 1191–1204. 114 indexed citations
3.
Shahaf, Gitit, Moshe Giladi, Rosa S. Schneiderman, et al.. (2020). Abstract 2411: Cancer cell lines meta-analysis according to both short-term and long-term responses to Tumor Treating Fields (TTFields). Cancer Research. 80(16_Supplement). 2411–2411. 1 indexed citations
4.
Munster, Mijal, Rosa S. Schneiderman, Yaara Porat, et al.. (2019). Abstract 307: The combined treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed inhibit mesothelioma cells in vitro. Cancer Research. 79(13_Supplement). 307–307. 1 indexed citations
5.
Zeevi, Einav, Rosa S. Schneiderman, Mijal Munster, et al.. (2019). The Combined Treatment of 150 kHz Tumor Treating Fields (TTFields) and FOLFOX Inhibit Gastric Cancer in Vitro. International Journal of Radiation Oncology*Biology*Physics. 105(1). E681–E681. 1 indexed citations
6.
Shteingauz, Anna, Yaara Porat, Tali Voloshin, et al.. (2018). AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields). Cell Death and Disease. 9(11). 1074–1074. 82 indexed citations
7.
Schneiderman, Rosa S., Moshe Giladi, Einav Zeevi, et al.. (2018). ANGI-11. TUMOR TREATING FIELDS (TTFIELDS) INHIBIT CANCER CELL MIGRATION AND INVASION BY INDUCING REORGANIZATION OF THE ACTIN CYTOSKELETON AND FORMATION OF CELL ADHESIONS. Neuro-Oncology. 20(suppl_6). vi30–vi30. 4 indexed citations
8.
Porat, Yaara, Moshe Giladi, Rosa S. Schneiderman, et al.. (2017). Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields). Journal of Visualized Experiments. 23 indexed citations
9.
Porat, Yaara, Moshe Giladi, Rosa S. Schneiderman, et al.. (2017). Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields). Journal of Visualized Experiments. 46 indexed citations
10.
Weinberg, Uri, Tali Voloshin, Noa Kaynan, et al.. (2017). Efficacy of Tumor Treating Fields (TTFields) and anti-PD-1 in non-small cell lung cancer (NSCLC) preclinical models. Annals of Oncology. 28. ii11–ii12. 1 indexed citations
11.
Giladi, Moshe, Mijal Munster, Rosa S. Schneiderman, et al.. (2017). Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells. Radiation Oncology. 12(1). 206–206. 118 indexed citations
12.
Bomzon, Zéev, Cornelia Wenger, Moshe Giladi, et al.. (2016). Quantifying the Effect of Electric Fields in the Frequency Range of 100-500 khz on Mitotic Spindle Structures. Biophysical Journal. 110(3). 619a–619a. 1 indexed citations
13.
Porat, Yaara, Anna Shteingauz, Moshe Giladi, et al.. (2016). Abstract 3543: Alternating electric fields (TTFields) induce autophagy in human cancer cell lines. Cancer Research. 76(14_Supplement). 3543–3543. 2 indexed citations
14.
Munster, Mijal, Roni Blat, Paul C. Roberts, et al.. (2016). Abstract B79: Translational study of tumor treating fields in combination with paclitaxel in ovarian cancer.. Clinical Cancer Research. 22(2_Supplement). B79–B79. 1 indexed citations
15.
Munster, Mijal, Eva M. Schmelz, Moshe Giladi, et al.. (2015). Abstract 5365: Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo. Cancer Research. 75(15_Supplement). 5365–5365. 2 indexed citations
16.
Schneiderman, Rosa S., Moshe Giladi, Yaara Porat, et al.. (2014). Abstract 5521: TTFields reduce cancer cell clonogenic potential through abnormal chromosome segregation during mitosis. Cancer Research. 74(19_Supplement). 5521–5521. 1 indexed citations
17.
Giladi, Moshe, Rosa S. Schneiderman, Yaara Porat, et al.. (2013). Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields. Pancreatology. 14(1). 54–63. 75 indexed citations
18.
Giladi, Moshe, Rosa S. Schneiderman, Yaara Porat, et al.. (2013). Abstract 5569: Tumor Treating Fields inhibit the growth of pancreatic and ovarian cancer in preclinical models .. Cancer Research. 73(8_Supplement). 5569–5569. 1 indexed citations
19.
Sherman, Gayle, et al.. (2000). LOW MOLECULAR WEIGHT HEPARIN IN THE SUCCESSFUL TREATMENT OF A SPONTANEOUS AORTIC THROMBOSIS IN A NEONATE. Pediatric Hematology and Oncology. 17(5). 409–413. 11 indexed citations
20.
Frame, Kelly K., et al.. (1992). Monitoring and Control of Mammalian Cell Cultures. IFAC Proceedings Volumes. 25(2). 21–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shay Cahal Breakdown of academic impact, for papers by Roni Blat Breakdown of academic impact, for papers by Anna Shteingauz Breakdown of academic impact, for papers by Tali Voloshin Breakdown of academic impact, for papers by Einav Zeevi Breakdown of academic impact, for papers by Noa Kaynan Breakdown of academic impact, for papers by Manuela Silginer Breakdown of academic impact, for papers by Almuth F. Keßler Breakdown of academic impact, for papers by Sonia Tejada Breakdown of academic impact, for papers by Eduard B. Dinca
Rankless by CCL
2026